ESMO21: Roche’s giredestrant takes stage in battle of the oral SERDsRoche has revealed the first phase 2 clinical data with giredestrant, one of a clutch of new selective Share XESMO21: Roche’s giredestrant takes stage in battle of the oral SERDshttps://pharmaphorum.com/news/esmo21-roches-giredestrant-takes-stage-in-battle-of-the-oral-serds/
